Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Change in Accured Expenses (2024 - 2025)

Carlsmed (CARL) has disclosed Change in Accured Expenses for 2 consecutive years, with $97000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses fell 85.08% year-over-year to $97000.0, compared with a TTM value of $2.5 million through Dec 2025, changed N/A, and an annual FY2025 reading of $627000.0, down 48.35% over the prior year.
  • Change in Accured Expenses was $97000.0 for Q4 2025 at Carlsmed, down from $687000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $1.1 million in Q3 2024 and bottomed at $97000.0 in Q4 2025.